Suboptimal RAASi Therapy After Hyperkalemia Ups Cardiorenal

Hyperkalemia frequently results in suboptimal use of renin-angiotensin-aldosterone system inhibitor (RAASi) therapy and cardiorenal risks.

Related Keywords

Japan , Eiichiro Kanda , Kawasaki Medical School In Okayama , Kawasaki Medical School , United States , Market Clarity Data , Medical Data Vision ,